Director of the Institute for Memory Impairments and Nerological Disorders at UCI
University of California, IrvineClinical Trials, Neurodegenerative Disorders, Neuroscience
Dr. Grill has been the recipient of the National Alzheimer鈥檚 Coordinating Center Junior Investigator Award, the Alzheimer鈥檚 Association Turken Research Prize, the Community Spirit Award from OPICA Adult Day Services, and the P. Gene and Elaine Smith Term Chair in Alzheimer鈥檚 Disease Research. He has been funded by the National Institute on Aging, the National Institute of Neurological Disorders and Stroke, the Alzheimer鈥檚 Association, the Hartford Foundation, the BrightFocus Foundation, the American Federation for Aging Research, and the University of California. He is the co-leader of the Recruitment Unit and the Internal Ethics Committee for the NIH-funded Alzheimer鈥檚 Clinical Trial Consortium. He is a member of the Scientific Advisory Board for Maria Shriver鈥檚 Women鈥檚 Alzheimer鈥檚 Movement and for Lauren Rogen Miller and Seth Rogan's HfC. In 2017, he co-chaired a workgroup as part of the NIH鈥檚 Inclusion Across the Lifespan workshop, a congressional mandate in the 21st Century Cures Act (P.L. 114-255). He was part of a working group sponsored by the National Institute on Aging and the Alzheimer鈥檚 Association charged with creating a national strategy for recruitment to Alzheimer鈥檚 disease clinical research.
Alzheimer's Disease, Learning And Memory, Molecular Biology, Neurodegenerative Disorders
Frank M. LaFerla, Ph.D., is the dean of the UCI School of Biological Sciences and a chancellor鈥檚 professor in the Department of Neurobiology and Behavior. He joined UCI in 1995 as an assistant professor and later served as chair of Neurobiology and Behavior from 2010 to 2013 and the director of the UCI Institute for Memory Impairments and Neurological Disorders (UCI MIND) from 2009 鈥 2018. Dean LaFerla is the current director of the National Institutes of Health funded UCI Alzheimer鈥檚 Disease Research Center and the co-director of the National Institute on Aging funded Model-AD at UCI, a research consortium to develop the next generation of model organisms to evaluate and cure Alzheimer鈥檚 disease. His research focuses on understanding the pathogenesis of Alzheimer鈥檚 Disease, the most common form of dementia. His scholarly work has had a global influence on the field, as some of the model organisms he has generated have been distributed to over 150 researchers in more than 20 countries throughout the world. He has published more than 200 original peer-reviewed articles and has been listed among the top 1% cited researchers in his field. Dean LaFerla has received many honors for his research accomplishments throughout his career, including the Promising Work Award from the Metropolitan Life Foundation for Medical Research, the Ruth Salta Investigator Achievement Award from the American Health Assistance Foundation, the Zenith Fellows Award from the Alzheimer鈥檚 Association and the UCI Innovators Award. He is a fellow of the American Association for the Advancement of Science, and an elected member of the American Neurological Association, the American Society for Cell Biology, the International Society for Stem Cell Research and the Society for Neuroscience.